STOCK TITAN

Compass Lexecon Names Mary Coleman Head of U.S. Antitrust Practice

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Negative)
Tags

FTI Consulting (NYSE: FCN) has announced the appointment of Dr. Mary T. Coleman as Head of the U.S. Antitrust practice at its Compass Lexecon subsidiary. Dr. Coleman, an Executive Vice President based in Boston, brings extensive experience in competitive analysis of mergers, acquisitions, and antitrust litigation.

As the former Deputy Director for Antitrust in the Bureau of Economics at the Federal Trade Commission (2001-2004), Dr. Coleman was involved in all FTC antitrust investigations and played a key role in enhancing empirical content in investigations and improving cooperation between economic and legal staffs.

In her new role, she will oversee antitrust activities across all U.S. offices and coordinate with international colleagues. Dr. Coleman, who joined Compass Lexecon in 2009, is currently serving as Vice Chair of the Finance Committee in the American Bar Association Antitrust section.

FTI Consulting (NYSE: FCN) ha annunciato la nomina della Dr.ssa Mary T. Coleman come Responsabile della pratica Antitrust negli Stati Uniti presso la sua sussidiaria Compass Lexecon. La Dr.ssa Coleman, Vicepresidente Esecutivo con sede a Boston, porta con sé un'ampia esperienza nell'analisi competitiva di fusioni, acquisizioni e contenzioso antitrust.

In qualità di ex Vice Direttore per l'Antitrust nel Bureau of Economics della Federal Trade Commission (2001-2004), la Dr.ssa Coleman è stata coinvolta in tutte le indagini antitrust della FTC e ha svolto un ruolo chiave nel migliorare il contenuto empirico delle indagini e nel favorire la cooperazione tra i team economici e legali.

Nel suo nuovo ruolo, supervisionerà le attività antitrust in tutti gli uffici statunitensi e coordinerà con i colleghi internazionali. La Dr.ssa Coleman, che è entrata in Compass Lexecon nel 2009, attualmente ricopre la carica di Vice Presidente del Comitato Finanze nella sezione Antitrust dell'American Bar Association.

FTI Consulting (NYSE: FCN) ha anunciado el nombramiento de la Dra. Mary T. Coleman como Jefa de la práctica de Antimonopolio en EE. UU. en su subsidiaria Compass Lexecon. La Dra. Coleman, Vicepresidenta Ejecutiva con sede en Boston, aporta una amplia experiencia en el análisis competitivo de fusiones, adquisiciones y litigios antimonopolio.

Como ex Subdirectora de Antimonopolio en la Oficina de Economía de la Comisión Federal de Comercio (2001-2004), la Dra. Coleman estuvo involucrada en todas las investigaciones antimonopolio de la FTC y desempeñó un papel clave en la mejora del contenido empírico en las investigaciones y en la mejora de la cooperación entre los equipos económicos y legales.

En su nuevo rol, supervisará las actividades antimonopolio en todas las oficinas de EE. UU. y coordinará con colegas internacionales. La Dra. Coleman, quien se unió a Compass Lexecon en 2009, actualmente se desempeña como Vicepresidenta del Comité de Finanzas en la sección de Antimonopolio de la Asociación Americana de Abogados.

FTI Consulting (NYSE: FCN)는 Dr. Mary T. Coleman을 Compass Lexecon 자회사에서 미국 반독점 실무의 책임자로 임명했다고 발표했습니다. 보스턴에 본사를 둔 Executive Vice President인 Coleman 박사는 인수합병 및 반독점 소송에 대한 경쟁 분석 분야에서 풍부한 경험을 가지고 있습니다.

2001년부터 2004년까지 연방거래위원회(Federal Trade Commission) 경제국의 전 반독점 부국장으로서 Coleman 박사는 모든 FTC 반독점 조사에 참여했으며, 조사에서 경험적 내용을 강화하고 경제 및 법률 팀 간의 협력을 개선하는 데 중요한 역할을 했습니다.

새로운 역할에서 그녀는 미국 전역의 반독점 활동을 감독하고 국제 동료들과 조율할 것입니다. 2009년 Compass Lexecon에 합류한 Coleman 박사는 현재 미국 변호사 협회 반독점 섹션의 재정 위원회 부위원장으로 활동하고 있습니다.

FTI Consulting (NYSE: FCN) a annoncé la nomination de Dr. Mary T. Coleman en tant que Responsable de la pratique Antitrust aux États-Unis au sein de sa filiale Compass Lexecon. Dr. Coleman, Vice-Présidente Exécutive basée à Boston, apporte une vaste expérience dans l'analyse concurrentielle des fusions, acquisitions et litiges antitrust.

En tant qu'ancienne Directrice Adjointe de l'Antitrust au Bureau de l'Économie de la Commission Fédérale du Commerce (2001-2004), Dr. Coleman a participé à toutes les enquêtes antitrust de la FTC et a joué un rôle clé dans l'amélioration du contenu empirique des enquêtes et dans l'amélioration de la coopération entre les équipes économiques et juridiques.

Dans son nouveau rôle, elle supervisera les activités antitrust dans tous les bureaux américains et coordonnera avec ses collègues internationaux. Dr. Coleman, qui a rejoint Compass Lexecon en 2009, est actuellement Vice-Présidente du Comité des Finances de la section Antitrust de l'American Bar Association.

FTI Consulting (NYSE: FCN) hat die Ernennung von Dr. Mary T. Coleman zur Leiterin der Antitrust-Praxis in den USA bei ihrer Tochtergesellschaft Compass Lexecon bekannt gegeben. Dr. Coleman, Executive Vice President mit Sitz in Boston, bringt umfassende Erfahrung in der Wettbewerbsanalyse von Fusionen, Übernahmen und Antitrust-Rechtsstreitigkeiten mit.

Als ehemalige stellvertretende Direktorin für Antitrust im Bureau of Economics der Federal Trade Commission (2001-2004) war Dr. Coleman an allen Antitrust-Untersuchungen der FTC beteiligt und spielte eine Schlüsselrolle bei der Verbesserung des empirischen Inhalts in den Untersuchungen sowie der Verbesserung der Zusammenarbeit zwischen wirtschaftlichen und rechtlichen Abteilungen.

In ihrer neuen Rolle wird sie die Antitrust-Aktivitäten in allen US-Büros überwachen und mit internationalen Kollegen koordinieren. Dr. Coleman, die 2009 zu Compass Lexecon kam, ist derzeit stellvertretende Vorsitzende des Finanzausschusses der Antitrust-Sektion der American Bar Association.

Positive
  • Strategic leadership appointment strengthens FCN's antitrust consulting capabilities
  • Appointment of former FTC Deputy Director adds regulatory expertise to the firm
Negative
  • None.

WASHINGTON, March 10, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that Dr. Mary T. Coleman has been named Head of the U.S. Antitrust practice at its Compass Lexecon subsidiary.

Dr. Coleman is an Executive Vice President based in Boston. She specializes in the competitive analysis of mergers and acquisitions and joint ventures, as well as antitrust litigation, including liability and class-action certification issues. Dr. Coleman has made presentations before U.S. and foreign antitrust authorities, submitted expert testimony in federal court, and testified in state court. She is part of the American Bar Association Antitrust section leadership, currently serving as Vice Chair of the Finance Committee and previously as Chair of the Women.Connected and Economics Committees.

“I’m delighted to announce that Dr. Mary Coleman has been appointed to our newly created position of Head of U.S. Antitrust,” Compass Lexecon Chairman Daniel R. Fischel said. “Mary will now oversee antitrust activities in all our offices throughout the United States as well as be responsible for coordinating our U.S. activities with our international colleagues.”

“Compass Lexecon is the preeminent global economic consulting firm, and I am excited to take on this new role as Head of U.S. Antitrust,” Dr. Coleman said. “I look forward to leading our team in providing expert economic analysis on complex competition issues and helping clients navigate the evolving regulatory landscape."

From 2001 to 2004, Dr. Coleman was the Deputy Director for Antitrust in the Bureau of Economics at the Federal Trade Commission. In this role, she was involved in all antitrust investigations at the FTC, including mergers, horizontal restraints, monopolization and vertical issues and in several non-enforcement projects.

Dr. Coleman also managed the economic input into all antitrust cases and advised the Bureau of Competition staff lawyers and management, as well as the Commission. She was instrumental in the efforts of the Bureau of Economics to increase the empirical content of antitrust investigations at the FTC and to facilitate cooperation between economic and legal staffs, and she worked extensively to improve cooperation between the FTC and foreign jurisdictions.

Dr. Coleman joined Compass Lexecon in 2009 and was previously a Managing Director at LECG.

About FTI Consulting
FTI Consulting, Inc. is a leading global expert firm for organizations facing crisis and transformation, with more than 8,300 employees in 34 countries and territories as of December 31, 2024. The Company generated $3.69 billion in revenues during fiscal year 2024. In certain jurisdictions, FTI Consulting’s services are provided through distinct legal entities that are separately capitalized and independently managed. More information can be found at www.fticonsulting.com.

FTI Consulting, Inc.
555 12th Street NW
Washington, DC 20004
+1.202.312.9100

Investor Contact:
Mollie Hawkes
+1.617.747.1791
mollie.hawkes@fticonsulting.com

Media Contact:
Matthew Bashalany
+1.617.897.1545
matthew.bashalany@fticonsulting.com


FAQ

What is Dr. Mary Coleman's new role at FTI Consulting's (FCN) Compass Lexecon?

Dr. Coleman has been appointed as Head of the U.S. Antitrust practice at Compass Lexecon, where she will oversee antitrust activities across all U.S. offices and coordinate with international colleagues.

What was Dr. Coleman's previous experience at the Federal Trade Commission?

From 2001 to 2004, she served as Deputy Director for Antitrust in the Bureau of Economics at the FTC, overseeing all antitrust investigations and improving cooperation between economic and legal staffs.

When did Dr. Coleman join FCN's Compass Lexecon subsidiary?

Dr. Coleman joined Compass Lexecon in 2009, after previously working as a Managing Director at LECG.

What are Dr. Coleman's areas of expertise at FCN's Compass Lexecon?

She specializes in competitive analysis of mergers and acquisitions, joint ventures, and antitrust litigation, including liability and class-action certification issues.
Fti Consulting Inc

NYSE:FCN

FCN Rankings

FCN Latest News

FCN Stock Data

5.86B
35.35M
1.46%
99.29%
1.07%
Consulting Services
Services-management Consulting Services
Link
United States
WASHINGTON